Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma
Identifieur interne : 001F47 ( Istex/Corpus ); précédent : 001F46; suivant : 001F48Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma
Auteurs : L. Lee ; M. Pintilie ; D. C. Hodgson ; P. E. Goss ; M. CrumpSource :
- Annals of Oncology [ 0923-7534 ] ; 2007-09-17.
Abstract
Background: Female survivors of Hodgkin's lymphoma (HL) treated with supradiaphragmatic radiation therapy (SRT) are at increased risk of breast cancer (BC), but there is little data on the optimal screening strategy. Patient and methods: We report a prospective surveillance study of women treated for HL with SRT before age 30 participating in a high-risk screening clinic. Starting 8 years after treatment, women received annual mammography and clinical follow-up from 1997 to 2006. Method of detection and characteristics of BCs were identified. Results: In all, 115 female HL survivors attended at least one clinic; 100 participated in annual surveillance. The majority had mammography alone; adjunctive magnetic resonance imaging (MRI) was used more frequently in women with high breast density (P0.025). Median age at first mammogram was 36 years and decreased with more recent year of diagnosis. Twelve of the 100 participating women (12%) were diagnosed with BC after a median of 5 years of surveillance (range, 19). Seven BCs presented as palpable masses [six invasive, one ductal carcinoma in situ (DCIS)], five were detected by mammography (one invasive, four DCIS). Conclusions: Despite earlier initiation of mammographic screening, most BCs were detected clinically and had unfavorable pathologic characteristics. Evaluation of more intensive screening and the contribution of MRI for earlier detection is warranted.
Url:
DOI: 10.1093/annonc/mdm440
Links to Exploration step
ISTEX:CE8CC5386BBA9B947B6D54D718118FB867BB1214Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma</title><author><name sortKey="Lee, L" sort="Lee, L" uniqKey="Lee L" first="L." last="Lee">L. Lee</name><affiliation><mods:affiliation>Division of Medical Oncology and Hematology</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: michael.crump@uhn.on.ca</mods:affiliation></affiliation></author><author><name sortKey="Pintilie, M" sort="Pintilie, M" uniqKey="Pintilie M" first="M." last="Pintilie">M. Pintilie</name><affiliation><mods:affiliation>Department of Biostatistics</mods:affiliation></affiliation></author><author><name sortKey="Hodgson, D C" sort="Hodgson, D C" uniqKey="Hodgson D" first="D. C." last="Hodgson">D. C. Hodgson</name><affiliation><mods:affiliation>Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Goss, P E" sort="Goss, P E" uniqKey="Goss P" first="P. E." last="Goss">P. E. Goss</name><affiliation><mods:affiliation>Division of Medical Oncology and Hematology, Massachusetts General Hospital Cancer Center, USA</mods:affiliation></affiliation></author><author><name sortKey="Crump, M" sort="Crump, M" uniqKey="Crump M" first="M." last="Crump">M. Crump</name><affiliation><mods:affiliation>Division of Medical Oncology and Hematology</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: michael.crump@uhn.on.ca</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:CE8CC5386BBA9B947B6D54D718118FB867BB1214</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1093/annonc/mdm440</idno><idno type="url">https://api.istex.fr/document/CE8CC5386BBA9B947B6D54D718118FB867BB1214/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001F47</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma</title><author><name sortKey="Lee, L" sort="Lee, L" uniqKey="Lee L" first="L." last="Lee">L. Lee</name><affiliation><mods:affiliation>Division of Medical Oncology and Hematology</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: michael.crump@uhn.on.ca</mods:affiliation></affiliation></author><author><name sortKey="Pintilie, M" sort="Pintilie, M" uniqKey="Pintilie M" first="M." last="Pintilie">M. Pintilie</name><affiliation><mods:affiliation>Department of Biostatistics</mods:affiliation></affiliation></author><author><name sortKey="Hodgson, D C" sort="Hodgson, D C" uniqKey="Hodgson D" first="D. C." last="Hodgson">D. C. Hodgson</name><affiliation><mods:affiliation>Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada</mods:affiliation></affiliation></author><author><name sortKey="Goss, P E" sort="Goss, P E" uniqKey="Goss P" first="P. E." last="Goss">P. E. Goss</name><affiliation><mods:affiliation>Division of Medical Oncology and Hematology, Massachusetts General Hospital Cancer Center, USA</mods:affiliation></affiliation></author><author><name sortKey="Crump, M" sort="Crump, M" uniqKey="Crump M" first="M." last="Crump">M. Crump</name><affiliation><mods:affiliation>Division of Medical Oncology and Hematology</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: michael.crump@uhn.on.ca</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Annals of Oncology</title><idno type="ISSN">0923-7534</idno><idno type="eISSN">1569-8041</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="2007-09-17">2007-09-17</date><biblScope unit="volume">19</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="62">62</biblScope><biblScope unit="page" to="67">67</biblScope></imprint><idno type="ISSN">0923-7534</idno></series><idno type="istex">CE8CC5386BBA9B947B6D54D718118FB867BB1214</idno><idno type="DOI">10.1093/annonc/mdm440</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0923-7534</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Background: Female survivors of Hodgkin's lymphoma (HL) treated with supradiaphragmatic radiation therapy (SRT) are at increased risk of breast cancer (BC), but there is little data on the optimal screening strategy. Patient and methods: We report a prospective surveillance study of women treated for HL with SRT before age 30 participating in a high-risk screening clinic. Starting 8 years after treatment, women received annual mammography and clinical follow-up from 1997 to 2006. Method of detection and characteristics of BCs were identified. Results: In all, 115 female HL survivors attended at least one clinic; 100 participated in annual surveillance. The majority had mammography alone; adjunctive magnetic resonance imaging (MRI) was used more frequently in women with high breast density (P0.025). Median age at first mammogram was 36 years and decreased with more recent year of diagnosis. Twelve of the 100 participating women (12%) were diagnosed with BC after a median of 5 years of surveillance (range, 19). Seven BCs presented as palpable masses [six invasive, one ductal carcinoma in situ (DCIS)], five were detected by mammography (one invasive, four DCIS). Conclusions: Despite earlier initiation of mammographic screening, most BCs were detected clinically and had unfavorable pathologic characteristics. Evaluation of more intensive screening and the contribution of MRI for earlier detection is warranted.</div></front></TEI><istex><corpusName>oup</corpusName><author><json:item><name>L. Lee</name><affiliations><json:string>Division of Medical Oncology and Hematology</json:string><json:string>E-mail: michael.crump@uhn.on.ca</json:string></affiliations></json:item><json:item><name>M. Pintilie</name><affiliations><json:string>Department of Biostatistics</json:string></affiliations></json:item><json:item><name>D. C. Hodgson</name><affiliations><json:string>Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada</json:string></affiliations></json:item><json:item><name>P. E. Goss</name><affiliations><json:string>Division of Medical Oncology and Hematology, Massachusetts General Hospital Cancer Center, USA</json:string></affiliations></json:item><json:item><name>M. Crump</name><affiliations><json:string>Division of Medical Oncology and Hematology</json:string><json:string>E-mail: michael.crump@uhn.on.ca</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>original article</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>breast cancer</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Hodgkin's lymphoma</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>late complications</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>screening</value></json:item></subject><language><json:string>eng</json:string></language><abstract>Background: Female survivors of Hodgkin's lymphoma (HL) treated with supradiaphragmatic radiation therapy (SRT) are at increased risk of breast cancer (BC), but there is little data on the optimal screening strategy. Patient and methods: We report a prospective surveillance study of women treated for HL with SRT before age 30 participating in a high-risk screening clinic. Starting 8 years after treatment, women received annual mammography and clinical follow-up from 1997 to 2006. Method of detection and characteristics of BCs were identified. Results: In all, 115 female HL survivors attended at least one clinic; 100 participated in annual surveillance. The majority had mammography alone; adjunctive magnetic resonance imaging (MRI) was used more frequently in women with high breast density (P0.025). Median age at first mammogram was 36 years and decreased with more recent year of diagnosis. Twelve of the 100 participating women (12%) were diagnosed with BC after a median of 5 years of surveillance (range, 19). Seven BCs presented as palpable masses [six invasive, one ductal carcinoma in situ (DCIS)], five were detected by mammography (one invasive, four DCIS). Conclusions: Despite earlier initiation of mammographic screening, most BCs were detected clinically and had unfavorable pathologic characteristics. Evaluation of more intensive screening and the contribution of MRI for earlier detection is warranted.</abstract><qualityIndicators><score>6.351</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 791 pts</pdfPageSize><refBibsNative>false</refBibsNative><keywordCount>5</keywordCount><abstractCharCount>1429</abstractCharCount><pdfWordCount>3819</pdfWordCount><pdfCharCount>24611</pdfCharCount><pdfPageCount>6</pdfPageCount><abstractWordCount>211</abstractWordCount></qualityIndicators><title>Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma</title><genre.original><json:string>research-article</json:string></genre.original><genre><json:string>research-article</json:string></genre><host><volume>19</volume><publisherId><json:string>annonc</json:string></publisherId><pages><last>67</last><first>62</first></pages><issn><json:string>0923-7534</json:string></issn><issue>1</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1569-8041</json:string></eissn><title>Annals of Oncology</title></host><categories><wos><json:string>ONCOLOGY</json:string></wos></categories><publicationDate>2007</publicationDate><copyrightDate>2008</copyrightDate><doi><json:string>10.1093/annonc/mdm440</json:string></doi><id>CE8CC5386BBA9B947B6D54D718118FB867BB1214</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/CE8CC5386BBA9B947B6D54D718118FB867BB1214/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/CE8CC5386BBA9B947B6D54D718118FB867BB1214/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/CE8CC5386BBA9B947B6D54D718118FB867BB1214/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma</title><respStmt xml:id="ISTEX-API" resp="Références bibliographiques récupérées via GROBID" name="ISTEX-API (INIST-CNRS)"></respStmt><respStmt xml:id="ISTEX-API" resp="Références bibliographiques récupérées via GROBID" name="ISTEX-API (INIST-CNRS)"></respStmt></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Oxford University Press</publisher><availability><p>OUP</p></availability><date>2007-09-17</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma</title><author corresp="yes"><persName><forename type="first">L.</forename><surname>Lee</surname></persName><email>michael.crump@uhn.on.ca</email><affiliation></affiliation></author><author><persName><forename type="first">M.</forename><surname>Pintilie</surname></persName><affiliation></affiliation></author><author><persName><forename type="first">D. C.</forename><surname>Hodgson</surname></persName><affiliation></affiliation></author><author><persName><forename type="first">P. E.</forename><surname>Goss</surname></persName><affiliation></affiliation></author><author corresp="yes"><persName><forename type="first">M.</forename><surname>Crump</surname></persName><email>michael.crump@uhn.on.ca</email><affiliation></affiliation></author></analytic><monogr><title level="j">Annals of Oncology</title><idno type="pISSN">0923-7534</idno><idno type="eISSN">1569-8041</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="2007-09-17"></date><biblScope unit="volume">19</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="62">62</biblScope><biblScope unit="page" to="67">67</biblScope></imprint></monogr><idno type="istex">CE8CC5386BBA9B947B6D54D718118FB867BB1214</idno><idno type="DOI">10.1093/annonc/mdm440</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2007-09-17</date></creation><langUsage><language ident="en">en</language></langUsage><abstract><p>Background: Female survivors of Hodgkin's lymphoma (HL) treated with supradiaphragmatic radiation therapy (SRT) are at increased risk of breast cancer (BC), but there is little data on the optimal screening strategy. Patient and methods: We report a prospective surveillance study of women treated for HL with SRT before age 30 participating in a high-risk screening clinic. Starting 8 years after treatment, women received annual mammography and clinical follow-up from 1997 to 2006. Method of detection and characteristics of BCs were identified. Results: In all, 115 female HL survivors attended at least one clinic; 100 participated in annual surveillance. The majority had mammography alone; adjunctive magnetic resonance imaging (MRI) was used more frequently in women with high breast density (P0.025). Median age at first mammogram was 36 years and decreased with more recent year of diagnosis. Twelve of the 100 participating women (12%) were diagnosed with BC after a median of 5 years of surveillance (range, 19). Seven BCs presented as palpable masses [six invasive, one ductal carcinoma in situ (DCIS)], five were detected by mammography (one invasive, four DCIS). Conclusions: Despite earlier initiation of mammographic screening, most BCs were detected clinically and had unfavorable pathologic characteristics. Evaluation of more intensive screening and the contribution of MRI for earlier detection is warranted.</p></abstract><textClass><keywords scheme="keyword"><list><item><term>original article</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>Keywords</head><item><term>breast cancer</term></item><item><term>Hodgkin's lymphoma</term></item><item><term>late complications</term></item><item><term>screening</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2007-09-17">Created</change><change when="2007-09-17">Published</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2016-3-15">References added</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2016-3-22">References added</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/CE8CC5386BBA9B947B6D54D718118FB867BB1214/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus oup" wicri:toSee="no header"><istex:docType PUBLIC="-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" URI="journalpublishing.dtd" name="istex:docType"></istex:docType><istex:document><article article-type="research-article"><front><journal-meta><journal-id journal-id-type="publisher-id">annonc</journal-id><journal-id journal-id-type="hwp">annonc</journal-id><journal-title>Annals of Oncology</journal-title><issn pub-type="epub">1569-8041</issn><issn pub-type="ppub">0923-7534</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1093/annonc/mdm440</article-id><article-categories><subj-group><subject>original article</subject><subj-group><subject>breast cancer</subject></subj-group></subj-group></article-categories><title-group><article-title>Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Lee</surname><given-names>L.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pintilie</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hodgson</surname><given-names>D. C.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Goss</surname><given-names>P. E.</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Crump</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Division of Medical Oncology and Hematology</aff><aff id="aff2"><label>2</label>Department of Biostatistics</aff><aff id="aff3"><label>3</label>Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada</aff><aff id="aff4"><label>4</label>Division of Medical Oncology and Hematology, Massachusetts General Hospital Cancer Center, USA</aff><author-notes><corresp id="cor1"><label>*</label><italic>Correspondence to:</italic> Dr M. Crump, Princess Margaret Hospital, Room 5-108, 610 University Avenue, Toronto, Ontario, M5G 2M9, Canada. Tel: +1-416-946-4567; Fax: +1-416-946-6546; E-mail: <email>michael.crump@uhn.on.ca</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>1</month><year>2008</year></pub-date><pub-date pub-type="epub"><day>17</day><month>9</month><year>2007</year></pub-date><volume>19</volume><issue>1</issue><fpage>62</fpage><lpage>67</lpage><history><date date-type="received"><day>10</day><month>7</month><year>2007</year></date><date date-type="rev-recd"><day>30</day><month>7</month><year>2007</year></date><date date-type="accepted"><day>3</day><month>8</month><year>2007</year></date></history><permissions><copyright-statement>© 2007 European Society for Medical Oncology. For Permissions, please email: journals.permissions@oxfordjournals.org</copyright-statement><copyright-year>2008</copyright-year></permissions><abstract><p><bold>Background:</bold> Female survivors of Hodgkin's lymphoma (HL) treated with supradiaphragmatic radiation therapy (SRT) are at increased risk of breast cancer (BC), but there is little data on the optimal screening strategy.</p><p><bold>Patient and methods:</bold> We report a prospective surveillance study of women treated for HL with SRT before age 30 participating in a high-risk screening clinic. Starting 8 years after treatment, women received annual mammography and clinical follow-up from 1997 to 2006. Method of detection and characteristics of BCs were identified.</p><p><bold>Results:</bold> In all, 115 female HL survivors attended at least one clinic; 100 participated in annual surveillance. The majority had mammography alone; adjunctive magnetic resonance imaging (MRI) was used more frequently in women with high breast density (<italic>P</italic> = 0.025). Median age at first mammogram was 36 years and decreased with more recent year of diagnosis. Twelve of the 100 participating women (12%) were diagnosed with BC after a median of 5 years of surveillance (range, 1–9). Seven BCs presented as palpable masses [six invasive, one ductal carcinoma <italic>in situ</italic> (DCIS)], five were detected by mammography (one invasive, four DCIS).</p><p><bold>Conclusions:</bold> Despite earlier initiation of mammographic screening, most BCs were detected clinically and had unfavorable pathologic characteristics. Evaluation of more intensive screening and the contribution of MRI for earlier detection is warranted.</p></abstract><kwd-group><kwd>breast cancer</kwd><kwd>Hodgkin's lymphoma</kwd><kwd>late complications</kwd><kwd>screening</kwd></kwd-group></article-meta></front></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma</title></titleInfo><name type="personal" displayLabel="corresp"><namePart type="given">L.</namePart><namePart type="family">Lee</namePart><affiliation>Division of Medical Oncology and Hematology</affiliation><affiliation>E-mail: michael.crump@uhn.on.ca</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Pintilie</namePart><affiliation>Department of Biostatistics</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D. C.</namePart><namePart type="family">Hodgson</namePart><affiliation>Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P. E.</namePart><namePart type="family">Goss</namePart><affiliation>Division of Medical Oncology and Hematology, Massachusetts General Hospital Cancer Center, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal" displayLabel="corresp"><namePart type="given">M.</namePart><namePart type="family">Crump</namePart><affiliation>Division of Medical Oncology and Hematology</affiliation><affiliation>E-mail: michael.crump@uhn.on.ca</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="research-article"></genre><subject><topic>original article</topic></subject><originInfo><publisher>Oxford University Press</publisher><dateIssued encoding="w3cdtf">2007-09-17</dateIssued><dateCreated encoding="w3cdtf">2007-09-17</dateCreated><copyrightDate encoding="w3cdtf">2008</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract>Background: Female survivors of Hodgkin's lymphoma (HL) treated with supradiaphragmatic radiation therapy (SRT) are at increased risk of breast cancer (BC), but there is little data on the optimal screening strategy. Patient and methods: We report a prospective surveillance study of women treated for HL with SRT before age 30 participating in a high-risk screening clinic. Starting 8 years after treatment, women received annual mammography and clinical follow-up from 1997 to 2006. Method of detection and characteristics of BCs were identified. Results: In all, 115 female HL survivors attended at least one clinic; 100 participated in annual surveillance. The majority had mammography alone; adjunctive magnetic resonance imaging (MRI) was used more frequently in women with high breast density (P0.025). Median age at first mammogram was 36 years and decreased with more recent year of diagnosis. Twelve of the 100 participating women (12%) were diagnosed with BC after a median of 5 years of surveillance (range, 19). Seven BCs presented as palpable masses [six invasive, one ductal carcinoma in situ (DCIS)], five were detected by mammography (one invasive, four DCIS). Conclusions: Despite earlier initiation of mammographic screening, most BCs were detected clinically and had unfavorable pathologic characteristics. Evaluation of more intensive screening and the contribution of MRI for earlier detection is warranted.</abstract><subject><genre>Keywords</genre><topic>breast cancer</topic><topic>Hodgkin's lymphoma</topic><topic>late complications</topic><topic>screening</topic></subject><relatedItem type="host"><titleInfo><title>Annals of Oncology</title></titleInfo><genre type="Journal">journal</genre><identifier type="ISSN">0923-7534</identifier><identifier type="eISSN">1569-8041</identifier><identifier type="PublisherID">annonc</identifier><identifier type="PublisherID-hwp">annonc</identifier><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>62</start><end>67</end></extent></part></relatedItem><identifier type="istex">CE8CC5386BBA9B947B6D54D718118FB867BB1214</identifier><identifier type="DOI">10.1093/annonc/mdm440</identifier><accessCondition type="use and reproduction" contentType="copyright">2007 European Society for Medical Oncology. For Permissions, please email: journals.permissions@oxfordjournals.org</accessCondition><recordInfo><recordContentSource>OUP</recordContentSource></recordInfo></mods></metadata><covers><json:item><original>true</original><mimetype>image/gif</mimetype><extension>gif</extension><uri>https://api.istex.fr/document/CE8CC5386BBA9B947B6D54D718118FB867BB1214/covers/gif</uri></json:item><json:item><original>true</original><mimetype>image/tiff</mimetype><extension>tiff</extension><uri>https://api.istex.fr/document/CE8CC5386BBA9B947B6D54D718118FB867BB1214/covers/tiff</uri></json:item></covers><annexes><json:item><original>true</original><mimetype>image/jpeg</mimetype><extension>jpeg</extension><uri>https://api.istex.fr/document/CE8CC5386BBA9B947B6D54D718118FB867BB1214/annexes/jpeg</uri></json:item></annexes><enrichments><istex:catWosTEI uri="https://api.istex.fr/document/CE8CC5386BBA9B947B6D54D718118FB867BB1214/enrichments/catWos"><teiHeader><profileDesc><textClass><classCode scheme="WOS">ONCOLOGY</classCode></textClass></profileDesc></teiHeader></istex:catWosTEI></enrichments><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/OcrV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F47 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001F47 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Ticri/CIDE
|area= OcrV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:CE8CC5386BBA9B947B6D54D718118FB867BB1214
|texte= Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma
}}
| This area was generated with Dilib version V0.6.32. |  |